ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,937.09
      1.61%
      US Tech 100
      20,606.40
      2.00%
      Dow Jones
      43,149.49
      1.48%
      Brent Oil
      81.105
      1.76%
      Bitcoin
      98,903.31
      2.48%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC

      6. Parnell Pharmaceuticals Holdings Ltd (CE) (PARNF) Quote

      Parnell Pharmaceuticals Holdings Ltd (CE)

      Parnell Pharmaceuticals Holdings Ltd (CE) (PARNF)

      USOTC
      0.12
      0.00
      ( 0.00% )
      Updated: 19:00:00
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.12
      Bid
      0.00
      Ask
      0.00
      Volume
      -
      0.00 Day's Range 0.00
      0.000001 52 Week Range 0.35
      Market Cap
      14.445M
      Previous Close
      0.12
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      28,467
      Shares Outstanding
      120,377,529
      Dividend Yield
      -
      PE Ratio
      -2.52
      Earnings Per Share (EPS)
      -0.05
      Revenue
      35.43M
      Net Profit
      -5.74M

      About Parnell Pharmaceuticals Holdings Ltd (CE)

      Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed... Parnell (OTC: PARNF) is a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal and human health solutions. Parnell is a technology and clinical science leader in dairy reproduction, marketing its proprietary brands estroPLAN and GONAbreed via its dedicated sales force and digital technology mySYNCH in the USA and Australia-New Zealand, and via distributors in other markets. Parnell has a rapidly growing contract manufacturing business supplying industry majors with specialized sterile injectable products. In companion animal, Parnell manufactures and markets its proprietary canine osteoarthritis brands Zydax and Glyde. For more information on the company and its products, please visit www.parnell.com. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.parnell.com
      Headquarters
      Sydney, New South Wales, Aus
      Founded
      -
      Parnell Pharmaceuticals Holdings Ltd (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker PARNF. The last closing price for Parnell Pharmaceuticals (CE) was $0.12. Over the last year, Parnell Pharmaceuticals (CE) shares have traded in a share price range of $ 0.000001 to $ 0.35.

      Parnell Pharmaceuticals (CE) currently has 120,377,529 shares outstanding. The market capitalization of Parnell Pharmaceuticals (CE) is $14.45 million. Parnell Pharmaceuticals (CE) has a price to earnings ratio (PE ratio) of -2.52.

      Ask ADVFN Intelligence (AI)

      PARNF Latest News

      More News

      FeaturedZefiro Methane Corp. Subsidiary Awarded Slate of Government of Ohio-Funded Environmental Remediation Projects

      6 hours ago

      FeaturedMawson Finland Begins 2025 Drill Program, Mobilizing Multiple Drill Rigs at Rajapalot

      6 hours ago

      Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ

      OVERLAND PARK, Kan., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

      December 19 2016
      GlobeNewswire Inc.

      Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the...

      OVERLAND PARK, Kan., Dec. 09, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

      December 09 2016
      GlobeNewswire Inc.

      Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility

      OVERLAND PARK, Kan., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

      November 22 2016
      GlobeNewswire Inc.

      Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016

      OVERLAND PARK, Kansas, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

      November 02 2016
      GlobeNewswire Inc.

      Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016

      OVERLAND PARK, Kan., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

      October 27 2016
      GlobeNewswire Inc.

      Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016

      OVERLAND PARK, Kan., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

      August 04 2016
      GlobeNewswire Inc.

      Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016

      OVERLAND PARK, Kan., July 26, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

      July 26 2016
      GlobeNewswire Inc.

      Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial

      OVERLAND PARK, Kan., May 31, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

      May 31 2016
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1000.120.120.125000.12CS
      4-0.23-65.71428571430.350.350.082228400.1282669CS
      120.071400.050.350.05284670.08767723CS
      260.11991199000.00010.351.0E-6206910.08616385CS
      520.119999119999001.0E-60.351.0E-6148680.08393423CS
      1560.11991199000.00010.351.0E-6133440.02875162CS
      2600.029933.18534961150.09010.891.0E-6124490.21523373CS

      PARNF - Frequently Asked Questions (FAQ)

      What is the current Parnell Pharmaceuticals (CE) share price?
      The current share price of Parnell Pharmaceuticals (CE) is $ 0.12
      How many Parnell Pharmaceuticals (CE) shares are in issue?
      Parnell Pharmaceuticals (CE) has 120,377,529 shares in issue
      What is the market cap of Parnell Pharmaceuticals (CE)?
      The market capitalisation of Parnell Pharmaceuticals (CE) is USD 14.45M
      What is the 1 year trading range for Parnell Pharmaceuticals (CE) share price?
      Parnell Pharmaceuticals (CE) has traded in the range of $ 0.000001 to $ 0.35 during the past year
      What is the PE ratio of Parnell Pharmaceuticals (CE)?
      The price to earnings ratio of Parnell Pharmaceuticals (CE) is -2.52
      What is the cash to sales ratio of Parnell Pharmaceuticals (CE)?
      The cash to sales ratio of Parnell Pharmaceuticals (CE) is 0.41
      What is the reporting currency for Parnell Pharmaceuticals (CE)?
      Parnell Pharmaceuticals (CE) reports financial results in AUD
      What is the latest annual turnover for Parnell Pharmaceuticals (CE)?
      The latest annual turnover of Parnell Pharmaceuticals (CE) is AUD 35.43M
      What is the latest annual profit for Parnell Pharmaceuticals (CE)?
      The latest annual profit of Parnell Pharmaceuticals (CE) is AUD -5.74M
      What is the registered address of Parnell Pharmaceuticals (CE)?
      The registered address for Parnell Pharmaceuticals (CE) is UNIT 4 CENTURY ESTATE, 476 GARDENERS ROAD, ALEXANDRIA, SYDNEY, NEW SOUTH WALES, 2015
      What is the Parnell Pharmaceuticals (CE) website address?
      The website address for Parnell Pharmaceuticals (CE) is www.parnell.com
      Which industry sector does Parnell Pharmaceuticals (CE) operate in?
      Parnell Pharmaceuticals (CE) operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      FBECFBEC Worldwide Inc (CE)
      $ 0.0002
      (19,900.00%)
      		1.02M
      FUVVArcimoto Inc (CE)
      $ 0.0002
      (19,900.00%)
      		793
      TNENTrue North Energy Corporation (CE)
      $ 0.0001
      (9,900.00%)
      		576.52k
      TLSSTransportation and Logistics Systems Inc (CE)
      $ 0.0001
      (9,900.00%)
      		56.39M
      DNAXDNA Brands Inc (PK)
      $ 0.0001
      (9,900.00%)
      		3.3M
      ZEUCFZeU Technologies Inc (CE)
      $ 0.000001
      (-99.97%)
      		1.62k
      THCBFTHC Biomed International Limited (CE)
      $ 0.000001
      (-99.90%)
      		20k
      MONDMondee Holdings Inc (PK)
      $ 0.0004
      (-99.85%)
      		1.23M
      DMTKQDermTech Inc (CE)
      $ 0.000001
      (-99.80%)
      		14.75k
      PGSCProgressive Green Solutions Inc (CE)
      $ 0.0001
      (-99.00%)
      		187.5k
      HMBLHUMBL Inc (PK)
      $ 0.001
      (0.00%)
      		593.67M
      TONRTonner One World Holdings Inc (PK)
      $ 0.0001
      (-50.00%)
      		234.35M
      ABQQAB International Group Corporation (PK)
      $ 0.0005
      (-28.57%)
      		182.42M
      TKMOTekumo Inc (PK)
      $ 0.0002
      (-33.33%)
      		173.06M
      ASIIAccredited Solutions Inc (PK)
      $ 0.0005
      (11.11%)
      		111.39M

      Discussion

      View Full Feed
      work-n-hard work-n-hard 4 minutes ago
      Unfortunately, this ticker seems to be doing what I observed MDCE going this same week.
      OTCN, who is well known for dumping shares for OTC companies, disappeared and ETRF stepped in and took over selling duties.
      For now, 2's are selling, but I suspect as soon as that's not the case, ET
      MDCE
      Gnarlyman Gnarlyman 4 minutes ago
      10% equity value keeps rising. That Jesse is a go-getter. New $500M bootstrap estimate. 

      https://x.com/jessetinsley?s=21&t=_YLIoordtKZeFPbQ_4Ezxw
      AESO
      Konaploinks Konaploinks 4 minutes ago
      I’d never believe him
      IONQ
      Singhania Singhania 4 minutes ago
      Quantum stocks are in big recovery mode and $ZENA could trigger another round of rally this week. The stock is still in a nice breakout and may hit $8.50-9
      ZENA
      WHITTENHALLJR WHITTENHALLJR 4 minutes ago
      Yeah missed it …
      CLHI
      Singhania Singhania 4 minutes ago
      Quantum stocks are in big recovery mode and $ZENA could trigger another round of rally this week. The stock is still in a nice breakout and may hit $8.50-9
      ZENA
      sqrl sqrl 4 minutes ago
      different business vertical than pluggable transceivers
      LWLG
      Susie924 Susie924 5 minutes ago
      This is bull shit

      https://apnews.com/article/flags-half-staff-trump-inauguration-johnson-a0c99a017e74b880df1c2eadfce25c28
      stock king 1 stock king 1 5 minutes ago
      Man has no news , he going to jail rumor has it
      VXIT
      Motor-goater Motor-goater 5 minutes ago
      Lmao. We pump what we can’t buy. You need to work on your material. The cracks are so wide the sun is shining through.
      CNNA
      Monksdream Monksdream 5 minutes ago
      ISRG (own it) new 52 week high
      https://investorshub.advfn.com/uimage/uploads/2025/1/15/k[xnsIMG_4627.gif
      ISRG
      bas2020 bas2020 5 minutes ago
      Perception by the scientific community
      Hailed by the scientific community as a world first, DCVax has received positive reviews for its revolutionary approach. Researchers and doctors see it as a paradigm shift in the treatment of brain cancers.

      With these results, the future s
      NWBO
      WorstLuck WorstLuck 5 minutes ago
      but it can be deferred if a BD opportunity is too good to pass up.

      Technically true yet trite.
      fza fza 5 minutes ago
      How much does one kilo of silk cocoons produce?
      The pupa is not necessarily a waste product as it is full of protein and can be used for food. Without the pupae, one kilo of whole cocoons becomes 200 to 230 grams of empty cocoons. The process of reeling silk from whole cocoons generates waste
      KBLB
      getmoreshares getmoreshares 5 minutes ago
      !!!!!!!!!!!!!!!!!!!!! GO GO GO !!!!!!!!!!!!!!!!!!!!!!!!!! thanks for the heads up- BREAK TIME
      BHAT
      stock king 1 stock king 1 5 minutes ago
      Don’t buy into the nonsense JK for 2025 imho
      VXIT
      JPetroInc JPetroInc 5 minutes ago
      that says it all - right there AB….!

      AJMHO
      MONI
      KVM KVM 6 minutes ago
      I guess the Needham conference also gave stock a jolt.lol
      VERI
      Large Green Large Green 6 minutes ago
      Solvency Certificate To Facilitate NSM Merger - NOTICE WORD-SMITHING TO OBFUSUCATE BILLIONS IN ASSET DISCLOSURE

      NOW THINK HOW MANY MORE BILLIONS ARE LEGALLY HIDDEN

      WaMu Holy Grail - Akim Gump Discuss Assets in Court

      Restricted Subsidiaries PLUS Footn
      WMB
      Involuntary-Recluse Involuntary-Recluse 6 minutes ago
      Well, he recently filed the Attorney Letter for EATR and its gazillion o/s, so the CLHI share structure is priceless IMHO ;-)
      CLHI EATR
      LutherTiggs LutherTiggs 6 minutes ago
      My guess would be price and terms. Doesn't mean they don't need/want it. Wouldn't be surprised if there are some ego considerations mixed in at some level...on either side of the equation. That will be Yves job to figure out and overcome.
      LWLG
      WHITTENHALLJR WHITTENHALLJR 6 minutes ago
      Will see I’m in + 1milly uggg
      HLLK
      CommodityCoverage CommodityCoverage 6 minutes ago
      Heliostar Metals (HSTR.v HSTXF) presents a compelling opportunity with its recent technical filings for three major projects in Mexico: La Colorada, San Agustin, and San Antonio as each project highlights the company’s strategic focus on economic efficiency, scalability, and sustainable operations:
      HSTXF
      vinsterr vinsterr 6 minutes ago
      A ton of volume this week, there’s still some hope it seems…
      TGGI

      Your Recent History

      USOTC
      PARNF
      Parnell Pharmaceuticals (CE)
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads